T
Takayuki Murase
Researcher at Nagoya City University
Publications - 60
Citations - 1297
Takayuki Murase is an academic researcher from Nagoya City University. The author has contributed to research in topics: Medicine & Carcinoma. The author has an hindex of 17, co-authored 51 publications receiving 1071 citations.
Papers
More filters
Journal ArticleDOI
Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients
Ichiro Fukai,Akira Masaoka,Yoshitaka Fujii,Yosuke Yamakawa,Tomoki Yokoyama,Takayuki Murase,Tadaaki Eimoto +6 more
TL;DR: Thymic neuroendocrine tumor must be regarded as a malignant neoplasm that is prone to metastasize to mediastinal lymph nodes and to distant sites, even after total excision.
Journal ArticleDOI
Immunohistochemical study of autoimmune pancreatitis using anti‐IgG4 antibody and patients' sera
Shigeru Aoki,Takahiro Nakazawa,Hirotaka Ohara,Hitoshi Sano,Haruhisa Nakao,Takashi Joh,Takayuki Murase,Tadaaki Eimoto,Makoto Itoh +8 more
TL;DR: The aim of the present study was to examine immunohistochemically which extrapancreatic organs are affected, and whether an autoantibody to such organs is present in the serum of AIP patients.
Journal ArticleDOI
Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers.
Yoshinori Ito,Yuji Okada,Mikinori Sato,Hiroztuni Sawai,Hitoshi Funahashi,Takayuki Murase,Tetsushi Hayakawa,Tadao Manabe +7 more
TL;DR: The expression of RET in pancreatic cancer tissues may be a useful prognostic marker and GDNF may play an important role in neural invasion.
Journal ArticleDOI
Sclerosing hemangioma with metastases to multiple nodal stations.
TL;DR: A case of a large pulmonary sclerosing hemangioma with metastases to multiple lymph nodal stations and suspected contralateral pulmonary metastasis is presented and lymph node dissection may be necessary to detect lymph node metastasis in selected cases.
Journal ArticleDOI
Immunoreactivity of a New CD5 Antibody with Normal Epithelium and Malignant Tumors Including Thymic Carcinoma
TL;DR: The NCL-CD5-4C7 positivity in thymic epithelial tumors may support the hypothesis suggesting progression of atypical thymoma toThymic carcinoma, and may be useful in the differential diagnosis of mediastinal tumors.